42735 studies found for:    Open Studies | Senior
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | Senior
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Evaluation of a Support Software in the Planning and Real-time Monitoring of the Insertion of Needles in Interventional Magnetic Resonance Imaging (MRI): Liver Biopsy Case
Condition: Liver Biopsy
Interventions: Device: Planning@IFE and Standard@IFE Software;   Device: MR Syngo (Numaris/4) software
2 Recruiting Incidence, Patient Characteristics, Pathophysiology, and Outcome of Perioperative Myocardial Injury After Non-cardiac Surgery
Condition: Perioperative Myocardial Injury
3 Not yet recruiting Gastrointestinal Motility Among Diabetic Patients
Conditions: Diabetic Autonomic Neuropathy;   Gastrointestinal Motility Disorder;   Diabetes Mellitus;   Change of Transit or Circulation
Interventions: Radiation: 11C Donepezil PET/CT scan;   Device: 3D-Transit;   Drug: 3D-Transit during treatment with Pyridostigmine
4 Recruiting Study of Consolidation Chemotherapy For Bulky Local Advanced None-small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer
Intervention: Drug: consolidation chemotherapy of AP or DP after CCRT
5 Not yet recruiting Nab-Paclitaxel and Cisplatin or Nab-paclitaxel as Induction Therapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC)
Conditions: Squamous Cell Carcinoma of the Head and Neck;   Carcinoma, Squamous Cell of the Head and Neck;   Cancer of Head and Neck;   Cancer of the Head and Neck;   Head and Neck Cancer;   Neoplasms, Head and Neck
Interventions: Drug: nab-Paclitaxel;   Drug: Cisplatin;   Biological: Cetuximab;   Radiation: Intensity-Modulated Radiation Therapy
6 Not yet recruiting An Extension Study of the Efficacy, Safety and Tolerability of BYM338 (Bimagrumab) in Patients With Sporadic Inclusion Body Myositis Who Previously Participated in the Core Study CBYM338B2203
Condition: Sporadic Inclusion Body Myositis
Interventions: Drug: Bimagrumab;   Drug: Placebo
7 Recruiting Prosocial Exercise: Does Exercising for Charity Result in Greater Well-Being and Physical Activity?
Condition: Sedentary Lifestyle
Intervention: Behavioral: App assignment
8 Not yet recruiting Pancreatic Duct Stenting to Prevent Postoperative Pancreatic Fistula (POPF) After Distal Pancreatectomy
Condition: Pancreatitis
Intervention: Device: Boston Scientific or Cook pancreatic duct stents
9 Not yet recruiting Antiviral Pharmacology and Adherence in Drug Users
Conditions: HEPATITIS C;   Virus, Human Immunodeficiency
Interventions: Behavioral: Directly Observed Therapy;   Behavioral: Wirelessly Observed Therapy
10 Not yet recruiting Selinexor With Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia
Condition: Acute Myeloid Leukemia
Interventions: Drug: Cytarabine;   Drug: Mitoxantrone Hydrochloride;   Drug: Selinexor
11 Recruiting A Study of ABT-414 in Subjects With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification
Conditions: Glioblastoma;   Gliosarcoma
Interventions: Drug: ABT-414;   Radiation: Radiation;   Drug: Temozolomide;   Drug: Placebo for ABT-414
12 Recruiting Actual Use Study of Tamsulosin in Men
Condition: Urological Manifestations
Intervention: Drug: tamsulosin hydrochloride
13 Recruiting Cryotherapy and Doppler in Inflammatory Rheumatic Diseases
Conditions: Rheumatoid Arthritis;   Crystal-induced Arthritides;   Spondyloarthritis
Interventions: Device: ice;   Device: cold gas
14 Recruiting Impact of Eslicarbazepine Acetate on Lipid Metabolism and Cardiovascular Risk Factors
Condition: Epilepsy
Intervention: Drug: eslicarbacepine
15 Not yet recruiting A Dose Escalation Study Of PF-06801591 In Melanoma, Head And Neck Cancer (SCHNC), Ovarian, Sarcoma, Hodgkin Lymphoma
Intervention: Drug: PF-06801591
16 Not yet recruiting Irinotecan Hydrochloride With FOLFIRI and Cetuximab as First-Line Therapy in Treating Patients With RAS Wild-Type Colorectal Cancer
Conditions: Stage IVA Colorectal Cancer;   Stage IVB Colorectal Cancer
Interventions: Biological: Cetuximab;   Drug: Fluorouracil;   Drug: Irinotecan Hydrochloride;   Drug: Leucovorin Calcium
17 Not yet recruiting Recovery of Hibernating Myocardium in End Stage Heart Failure
Conditions: Myocardial Function After LVAD Implant;   Ischemic Cardiomyopathy
18 Not yet recruiting A Study of the Safety, Tolerability, and Immunogenicity of V114 Compared With Prevnar 13™ in Healthy Adults 65 Years of Age or Older Previously Vaccinated With 23-valent Pneumococcal Polysaccharide Vaccine (V114-007)
Condition: Pneumococcal Infections
Interventions: Biological: V114;   Biological: Prevnar 13™
19 Not yet recruiting Pharmacogenomic Decision Support With GeneSight Psychotropic to Guide the Treatment of Schizophrenia/Schizoaffective Disorder
Conditions: Schizophrenia;   Schizoaffective Disorder
Interventions: Genetic: GeneSight Psychotropic (GEN);   Genetic: Enhanced-GeneSight Psychotropic (E-GEN);   Other: Treatment as Usual (TAU)
20 Not yet recruiting Two-part Safety, Tolerability, Pharmacodynamic and -Kinetic Study of Inhaled AZD8871 in Asthmatic and COPD Subjects
Conditions: Asthma (Part 1);   COPD (Part 2)
Interventions: Drug: Dose 1, AZD8871 50 μg (Part 1);   Drug: Dose 2, AZD8871 100 μg (Part 1);   Drug: Dose 3, AZD8871 300 μg (Part 1);   Drug: Dose 4, AZD8871 600 µg (Part 1);   Drug: Dose 5, AZD8871 1200 µg (Part 1);   Drug: Dose 6, AZD8871 1800 μg (Part 1);   Drug: Placebo, AZD8871 placebo (Part 1);   Drug: Treatment A, AZD8871 dose A (Part 2);   Drug: Treatment B, AZD8871 dose B (Part 2);   Drug: Treatment C, Indacaterol 150 μg (Part 2);   Drug: Treatment D, Tiotropium 18 μg (Part 2)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years